Autopsy report · NCT04231279

Recurrent Abdominal Pain and Exocrine Pancreatic Insufficiency

“Data collection discontinuity and sponsor reallocation of study resources to manufacturing”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 years 1 month before it started.
• Ran for about 1 year 5 months before it stopped.
• 27 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Orlando Health, Inc.

Sponsor type

University, hospital or other

Conditions

Abdominal Pain; Irritable Bowel Syndrome

Interventions

synthetic human secretin

Participants

27

Sites

1

Countries

United States

Trials that died the same way

• Journey II BCS CMS Total Knee System Compared to Other PS Total Knee Systems in PT Setting
  “Logistics of study did not allow for consistent data collection” (65% match in meaning)
• Azithromycin for Severe Acute Malnutrition in CMAM, Nigeria
  “Study was halted due to low follow-up rates and issues with data collection” (58% match in meaning)
• Feasibility and Impact of Volume Targeted Ventilation in the Delivery Room
  “Discontinuation of the study Product by manufacturer” (57% match in meaning)
• Guanfacine for Hyperactivity in Children With Down Syndrome (HYPEbeGONE_DS)
  “Study was stopped after careful review of product manufacturing needs and available resources. Decision reflects consideration of feasibility, enrollment challenges, and overall program goals.” (56% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.